Artikler med krav om offentlig adgang - Kodera YasuhiroFå flere oplysninger
Ikke tilgængelige nogen steder: 3
Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma
S Sueoka, M Kanda, H Sugimoto, D Shimizu, S Nomoto, H Oya, H Takami, ...
Annals of surgical oncology 22, 1453-1460, 2015
Krav: US National Institutes of Health
KCNJ15 Expression and Malignant Behavior of Esophageal Squamous Cell Carcinoma
S Nakamura, M Kanda, M Koike, D Shimizu, S Umeda, N Hattori, ...
Annals of Surgical Oncology 27, 2559-2568, 2020
Krav: US National Institutes of Health
Pattern-Specific Transcriptomics Identifies ASGR2 as a Predictor of Hematogenous Recurrence of Gastric Cancer
H Tanaka, M Kanda, T Miwa, C Tanaka, D Kobayashi, S Umeda, ...
Molecular Cancer Research 16 (9), 1420-1429, 2018
Krav: US National Institutes of Health
Tilgængelige et sted: 28
Intratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma
K Yamamura, D Izumi, R Kandimalla, F Sonohara, Y Baba, N Yoshida, ...
Clinical cancer research 25 (20), 6170-6179, 2019
Krav: US National Institutes of Health, Cancer Prevention Research Institute of …
An exosome-based transcriptomic signature for noninvasive, early detection of patients with pancreatic ductal adenocarcinoma: a multicenter cohort study
K Nakamura, Z Zhu, S Roy, E Jun, H Han, RM Munoz, S Nishiwada, ...
Gastroenterology 163 (5), 1252-1266. e2, 2022
Krav: US National Institutes of Health, National Natural Science Foundation of China
Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer
S Roy, M Kanda, S Nomura, Z Zhu, Y Toiyama, A Taketomi, J Goldenring, ...
Molecular Cancer 21 (1), 42, 2022
Krav: US Department of Defense, US National Institutes of Health, US Department of …
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference
GL Baiocchi, D D’Ugo, D Coit, R Hardwick, P Kassab, A Nashimoto, ...
Gastric Cancer 19, 15-20, 2016
Krav: US National Institutes of Health
Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer
M Kanda, D Shimizu, S Nomoto, H Takami, S Hibino, H Oya, R Hashimoto, ...
Gastric Cancer 18, 288-296, 2015
Krav: US National Institutes of Health
A microRNA-based liquid biopsy signature for the early detection of esophageal squamous cell carcinoma: a retrospective, prospective and multicenter study
J Miyoshi, Z Zhu, A Luo, S Toden, X Zhou, D Izumi, M Kanda, T Takayama, ...
Molecular cancer 21 (1), 44, 2022
Krav: US National Institutes of Health, National Natural Science Foundation of …
Downregulation of DENND2D by promoter hypermethylation is associated with early recurrence of hepatocellular carcinoma
M Kanda, S Nomoto, H Oya, H Takami, S Hibino, M Hishida, M Suenaga, ...
International journal of oncology 44 (1), 44-52, 2013
Krav: US National Institutes of Health
A liquid biopsy signature for the detection of patients with early-onset colorectal cancer
K Nakamura, G Hernández, GG Sharma, Y Wada, JK Banwait, ...
Gastroenterology 163 (5), 1242-1251. e2, 2022
Krav: US National Institutes of Health
Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus
S Hibino, M Kanda, H Oya, H Takami, D Shimizu, S Nomoto, M Hishida, ...
Oncology reports 31 (2), 693-700, 2014
Krav: US National Institutes of Health
Genomewide expression profiling identifies a novel miRNA-based signature for the detection of peritoneal metastasis in patients with gastric cancer
T Shimura, S Toden, R Kandimalla, Y Toiyama, Y Okugawa, M Kanda, ...
Annals of surgery 274 (5), e425-e434, 2021
Krav: US National Institutes of Health, Cancer Prevention Research Institute of …
Assessment of the diagnostic efficiency of a liquid biopsy assay for early detection of gastric cancer
D Izumi, Z Zhu, Y Chen, S Toden, X Huo, M Kanda, T Ishimoto, D Gu, ...
JAMA Network Open 4 (8), e2121129-e2121129, 2021
Krav: US National Institutes of Health, National Natural Science Foundation of …
Transcriptomic profiling identifies a risk stratification signature for predicting peritoneal recurrence and micrometastasis in gastric cancer
IS Lee, H Lee, H Hur, M Kanda, JH Yook, BS Kim, Y Woo, Y Kodera, ...
Clinical Cancer Research 27 (8), 2292-2300, 2021
Krav: US National Institutes of Health
A genomewide transcriptomic approach identifies a novel gene expression signature for the detection of lymph node metastasis in patients with early stage gastric cancer
D Izumi, F Gao, S Toden, F Sonohara, M Kanda, T Ishimoto, Y Kodera, ...
EBioMedicine 41, 268-275, 2019
Krav: US National Institutes of Health, Research Grants Council, Hong Kong
Premature ligand-receptor interaction during biosynthesis limits the production of growth factor midkine and its receptor LDL receptor-related protein 1
K Sakamoto, G Bu, S Chen, Y Takei, K Hibi, Y Kodera, LM McCormick, ...
Journal of Biological Chemistry 286 (10), 8405-8413, 2011
Krav: US National Institutes of Health
G-protein subunit gamma-4 expression has potential for detection, prediction and therapeutic targeting in liver metastasis of gastric cancer
H Tanaka, M Kanda, T Miwa, S Umeda, K Sawaki, C Tanaka, ...
British Journal of Cancer 125 (2), 220-228, 2021
Krav: US National Institutes of Health
Identification of serum miRNA signature and establishment of a nomogram for risk stratification in patients with pancreatic ductal adenocarcinoma
R Kandimalla, T Shimura, S Mallik, F Sonohara, S Tsai, DB Evans, ...
Annals of surgery 275 (1), e229-e237, 2022
Krav: US National Institutes of Health
Fraser extracellular matrix complex subunit 1 promotes liver metastasis of gastric cancer
S Umeda, M Kanda, T Miwa, H Tanaka, C Tanaka, D Kobayashi, ...
International Journal of Cancer 146 (10), 2865-2876, 2020
Krav: US National Institutes of Health
Oplysninger om publikation og økonomisk støtte registreres automatisk af et computerprogram